 | Chemical mimics of bioactive protein surfaces, 2006 - 2011
Funded by: Australian Research Council |
 | Smarter Diagnostics Through Selective Chemical Tagging, 2006 - 2009
Funded by: Bio-Layer Pty Ltd |
 | Inhibitors Of West Nile Virus Protease As Antiviral Drugs, 2007 - 2009
Funded by: National Health and Medical Research Council |
 | Targeting A Complement Receptor That Regulates Inflammatory Disease, 2007 - 2009
Funded by: National Health and Medical Research Council |
 | From Chemical Architecture to Protein Surfaces, 2007 - 2009
Funded by: Australian Research Council, University Of Queensland |
 | DsbA inhibitors as potential antimicrobials, 2007 - 2009
Funded by: National Health and Medical Research Council |
 | The West Nile Viral Protease, NS3: A Target for Antiviral Drug and Vaccine Design, 2006 - 2006
Funded by: University Of Queensland |
 | The West Nile viral protease NS3: a target for antiviral drug and vaccine design, 2005 - 2005
Funded by: National Health and Medical Research Council |
 | ESEG_The rational design of non-covalent caspase inhibitors, 2005 - 2006
Funded by: University Of Queensland |
 | Development of novel and selective anticancer drugs derived from cysteine, 2005 - 2007
Funded by: National Health and Medical Research Council |
 | Chemical Insights to Peptide Helix-Sheet-Nanofibre Equilibria, 2005 - 2007
Funded by: Australian Research Council, University Of Queensland |
 | Australian Computational Molecular Science Network, 2004 - 2004
Funded by: Australian Research Council, University Of Queensland |
 | C3/C5 Convertase Inhibitors as a new class of anti-inflammatory drugs, 2004 - 2006
Funded by: National Health and Medical Research Council |
 | The Australian Protease Network, 2004 - 2004
Funded by: Australian Research Council, University Of Queensland, University Of Queensland |
 | Towards a clinical trial of anti-inflammatory drugs discovered by blocking enzymes., 2003 - 2004
Funded by: National Health and Medical Research Council |
 | Agonists and antagonists of the human complement C3a receptor, 2003 - 2005
Funded by: National Health and Medical Research Council |
 | Design And Development Of Small Molecules To Regulate Protease Activated Receptor Type 2, 2003 - 2005
Funded by: National Health and Medical Research Council |
 | Virtual Screening In Structure-Based Drug Design For Malaria, 2003 - 2005
Funded by: National Health and Medical Research Council |
 | A Robotic NMR Spectrometer for Accelerated Drug Discovery, 2002
Funded by: Research Infrastructure (Equip & Fac) Program |
 | Macrocyclic Peptidomimetics, 2002 - 2006
Funded by: Australian Research Council |
 | Metal Clips for Folding Peptides, 2002 - 2004
Funded by: Australian Research Council |
 | Towards new antiinflammatory drugs based on human immune defence, 2002 - 2002
Funded by: University Of Queensland |
 | Applications of C5a antagonists in vivo, 2000 - 2002
Funded by: National Health and Medical Research Council |
 | Design and development of inhibitors of the dengue virus protease as antiviral agents, 2000 - 2002
Funded by: National Health and Medical Research Council |
 | Development of specific inhibitors of parasitic enzymes, 2000 - 2002
Funded by: National Health and Medical Research Council |
| Page: | 1 2 |
| |
| Select all records |
| |